Marcus Claesson

Chief Executive Officer at SeqBiome

After a BSc in Chemical Engineering and MSc in Bioinformatics at Chalmers University of Technology in Gothenburg, Marcus completed his PhD at University College Cork (UCC) sequencing and comparing commensal Lactobacillus species. This was followed by postdoctoral fellowships mining probiotic bacteria and analysing the microbiomes of older people as part of the ELDERMET project. Marcus is now a PI at APC Microbiome Ireland, UCC, where his main research interests in the role of microbiota in inflammatory bowel disease, and methods development for 'omics' technologies. He is also coordinating the MSc programme in Bioinformatics and Computational Biology, and lectures on the subject to MSc, Microbiology and Genetics students. In 2020, Marcus co-founded SeqBiome Ltd, a spin-out company providing high-quality microbiome analysis for industry and academia.

Marcus_Claesson_BioTech_Pharma_Summit_2021_Gallery

Title: Unravelling the microbiome of inflammatory bowel disease